Abstract: A display device includes a substrate including a display area and a peripheral area disposed around the display area, a pad area disposed near an edge of the substrate, and a plurality of pads disposed in the pad area and arranged along the edge of the substrate. An end of a first pad, which is an outermost pad among the plurality of pads, is connected to a first end of a resistor. The first pad is disposed between the resistor and the edge of the substrate, and a second end of the resistor is connected to a wire.

Abstract: This invention relates to a polishing pad and a method for manufacturing the same. The polishing pad may include a top pad layer and a window block. The top pad layer may include a groove pattern formed on an upper surface of the top pad layer. A first hole may be formed through the top pad layer. The window block may be inserted into the first hole. The top pad layer and the window block may have a structure coincided with following Formula 1. 1.1 ? Gap + Thk RTPC Thk grv ? 3. Formula ? 1 In Formula 1, the gap may indicate a height difference between an upper surface of the top pad layer and an upper surface of the window block, the ThkRTPC may indicate a thickness of the window block, and the Thkgrv may indicate a depth of the groove pattern.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: The present invention relates to a feed additive comprising a Bacillus subtilis strain and a Bacillus licheniformis strain, a feed composition comprising the feed additive, and a method for producing the feed additive.

Abstract: The present disclosure relates to a super absorbent polymer film and a preparation method of the same. Specifically, it relates to a new type of super absorbent polymer film, which is thin and exhibits excellent absorption performance, flexibility and elasticity while having little change in the shape of products. In addition, the super absorbent polymer film of the present disclosure is free from scattering or leaking, and does not require an auxiliary substance such as pulp, so that products can be made thinner and the manufacturing process and costs may be reduced.

Abstract: The present disclosure relates to a preparation method for a super absorbent polymer film. Specifically, it relates to a preparation method for a new type of super absorbent polymer film, which is thin and exhibits excellent absorption performance while having excellent flexibility and mechanical properties. In addition, the super absorbent polymer film is free from scattering or leaking, and does not require an auxiliary substance such as pulp, so that products can be made thinner and the manufacturing process and costs may be reduced.

Abstract: Provided are a Bacillus subtilis CJBS303 strain and use thereof. Also, provided are a strain having an effect of reducing livestock manure-derived odors, a composition and a microbial preparation, each including the strain, and a feed composition including the composition.

Abstract: The present disclosure relates to a polymer film, a preparation method of the same, and a polymer film laminate. Specifically, it relates to a new type of polymer film, which is thin and exhibits excellent absorption performance while having excellent flexibility and mechanical properties. In addition, the polymer film is free from scattering or leaking, and does not require an auxiliary substance such as pulp, so that products can be made thinner and the manufacturing process and costs may be reduced. In addition, the present disclosure also relates to a preparation method of the above-described polymer film, and a polymer film laminate including the new type of polymer film.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: The present disclosure relates to a preparation method for a super absorbent polymer film. Specifically, it relates to a preparation method for a new type of super absorbent polymer film, which is thin and exhibits excellent absorption performance. In addition, the super absorbent polymer film of the present disclosure has excellent flexibility and excellent mechanical properties, is free from scattering or leaking, and does not require an auxiliary substance such as pulp, so that products can be made thinner and the manufacturing process and costs may be reduced.

Abstract: The present invention relates to a rubber composition having excellent abrasion resistance and improved tensile properties and viscoelasticity properties by controlling compatibility among rubber components, and a tire manufactured using the same.

Abstract: The present disclosure relates to a super absorbent polymer film and a preparation method of the same. Specifically, it relates to a new type of super absorbent polymer film, which is thin and exhibits excellent absorption performance and high tensile strength. In addition, the super absorbent polymer film of the present disclosure is free from scattering or leaking, and does not require an auxiliary substance such as pulp, so that products can be made thinner and the manufacturing process and costs may be reduced.

Abstract: A method for fabricating a capacitor includes forming a first electrode, forming a dielectric layer stack on the first electrode, the dielectric layer stack including an initial hafnium oxide layer and a seed layer having a doping layer embedded therein, forming a thermal source layer on the dielectric layer stack to crystallize the initial hafnium oxide into tetragonal hafnium oxide, and forming a second electrode on the thermal source layer.

Abstract: A pharmaceutical composition and a health functional food composition for alleviating eye fatigue containing, as active ingredients, compounds, particularly, luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide isolated from a Perilla frutescens (L.) Britton var. acuta (Thunb.) Kudo leaf extract have an effect of alleviating eye fatigue by increasing the contents of NO and cGMP associated with relaxation of ciliary smooth muscle cells isolated from rat's eyes and decreasing the content of [Ca2+]i, and increasing cGMP which is a factor associated with relaxation of the ciliary smooth muscle through an animal experiment. As a result, the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds extracted from Perilla frutescens (L.) Britton var. acuta (Thunb.) Kudo may be usefully used as a pharmaceutical composition and a health functional food composition having an eye fatigue alleviating effect as a Korean natural resource.

Abstract: The present invention relates to small lipid nanoparticles, a small lipid nanoparticle (SLNP)-based nanovaccine platform including same, and a combination treatment regimen with an immune checkpoint inhibitor. Lipid nanoparticies according to the present invention can easily deliver antigens and anionic drugs into cells, and exhibit strong anti-tumor effects when loaded with tumor-associated antigens. Particularly, a cancer vaccine kit according to the present invention including lipid nanoparticles according to the present invention as a first vaccine composition and lipid nanoparticles and an immune checkpoint inhibitor as a second vaccine composition can be used to effectively suppress tumor regrowth and recurrence triggered by the occurrence of immunosuppression against a cancer nanovaccine.

Abstract: A method for fabricating a capacitor includes forming a first electrode, forming a dielectric layer stack on the first electrode, the dielectric layer stack including an initial hafnium oxide layer and a seed layer having a doping layer embedded therein, forming a thermal source layer on the dielectric layer stack to crystallize the initial hafnium oxide into tetragonal hafnium oxide, and forming a second electrode on the thermal source layer.

Abstract: The display device includes a substrate including a display area and a non-display area, a light-emitting element layer in the display and non-display areas, a color conversion layer including a bank in the display and non-display areas, a capping layer in the display and non-display areas and covering the bank, a plurality of color filters in the display and non-display areas and the plurality of color filters in the non-display area overlapping each other, and an overcoat layer in the display and non-display areas and covering the plurality of color filters. Each of the substrate, the capping layer, the plurality of color filters, and the overcoat layer has a lateral side which is furthest from the display area, and the lateral sides of the substrate, the capping layer, each of the plurality of color filters, and the overcoat layer are aligned with one another.

Abstract: A modified conjugated diene-based polymer, and more particularly, a modified conjugated diene-based polymer having a unimodal molecular weight distribution curve measured by gel permeation chromatography (GPC), molecular weight distribution (PDI; MWD) of less than 1.7, and a Si content of 100 ppm or more based on weight, and including a repeating unit derived from an aromatic vinyl monomer in an amount from 15 wt % to less than 30 wt %, and a rubber composition including the same.

Abstract: A modified conjugated diene-based polymer and a rubber composition including the same are disclosed herein. The modified conjugated diene-based polymer has excellent processability and good tensile strength and viscoelasticity. In some embodiments, a modified conjugated diene-based polymer includes a derived unit from a modifier, the modifier including three or more alkoxy groups bonded to silicon; a non-functional chain forming a silicon-carbon bond at one side of the derived unit from a modifier and including a repeating unit derived from a conjugated diene-based monomer; and a functional chain forming a silicon-carbon bond at the other side of the derived unit from a modifier and including two or more derived units from an N-functional group-containing monomer.

Abstract: Formulations for treating or preventing neuronal damage and/or the associated cognitive decline or impairment, caused by Alzheimer's disease and/or other neurodegenerative diseases, contain a therapeutic agent and a pharmaceutically acceptable carrier, wherein the therapeutic agent is dissolved in the pharmaceutically acceptable carrier. The formulations provide a safe, stable, convenient way to store and deliver high concentrations of the therapeutic agent, particularly when the therapeutic agent is lipophilic. The therapeutic agent can be a neurosteroid, a derivative or analogue thereof, or a pharmaceutically acceptable salt of the neurosteroid or its derivative or analogue. The pharmaceutically acceptable carrier can contain water, one or more lipophilic compounds, a surfactant, and optionally a co-surfactant. Generally, the carrier forms a stable microemulsion.